Importantly, several clinical studies have reported that circulating HMGB1 protein levels correlate with DN severity, including associations with reduced eGFR, increased albuminuria, and progression to advanced renal fibrosis, suggesting that HMGB1 biology is linked to both inflammation and structural kidney damage. Here, HMGB1 is linked to liver dysplastic nodule.